Apr 13, 2026 01:54AM
Feb 3, 2026 08:00AM
Nov 12, 2025 07:43AM
Nov 6, 2025 08:00AM
Oct 27, 2025 06:44AM
Oct 20, 2025 10:20AM
Oct 20, 2025 08:59AM Wedbush Upgrades Replimune Group (REPL) to Outperform
Oct 20, 2025 07:02AM
Oct 20, 2025 07:00AM
Jul 22, 2025 08:52AM
Jul 7, 2025 06:36AM
Jun 25, 2025 07:04AM
Jun 20, 2025 06:09AM
Jun 3, 2025 10:07AM JPMorgan Reiterates Overweight Rating on Replimune Group (REPL)
Jun 2, 2025 06:43AM
May 22, 2025 07:00AM
Feb 13, 2025 06:48AM
Feb 12, 2025 08:00AM
Jan 21, 2025 11:00AM
Jan 21, 2025 08:05AM
Jan 21, 2025 08:00AM Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma
Dec 3, 2024 03:59PM
Nov 22, 2024 09:08AM

15,439 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All